How does lacosamide work clinically?

Lens adapted to this topic: Open mechanistic questions around a settled clinical role

The dissent is not mainly about whether lacosamide can reduce seizures, but about how completely its biology is understood. CRMP2 binding has been reported as an additional action, while commentary notes that its behavior in generalized epilepsy is still not fully explained by the conventional “sodium drug” model. These ideas refine rather than overturn its established clinical use.

• Some literature describes CRMP2 binding as a second potential mechanism, although its precise contribution to clinical antiseizure effects is not established in the supplied evidence.
• Lacosamide’s effectiveness in generalized tonic-clonic seizures creates a mechanistic puzzle because it is commonly characterized as a sodium-channel drug, and the basis of that broader activity remains under discussion.
• The alternative interpretation challenges an overly simple mechanism label, not the clinical observation that lacosamide is used to control specified seizure types.

Featured sourceLacosamide for the prevention of partial onset seizures in ...pmc.ncbi.nlm.nih.gov3 sourcesView sources